Study Details
Expanded Access Treatment with Open-Label Pegunigalsidase Alfa for Fabry Patients
(IRB#: IRB_00140105)
Expanded Access Treatment with Open-Label Pegunigalsidase Alfa for Fabry Patients.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Unpaid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?
No
IRB#: IRB_00140105
PI: Nicola Longo
Department: PEDIATRIC GENETICS
Approval Date: 2021-04-07 06:00:00
Specialties: Pediatric Genetics